Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KIF18B promotes the proliferation of pancreatic ductal adenocarcinoma via activating the expression of CDCA8

26 Dec 2019

Abstract excerpt

Pancreatic cancer is one of the malignant tumors with the worst prognosis, and the 5-year survival rate of this disease is less than 1%. About 90% of pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC), and targeting therapy has become a promising treatment for PDAC in recent years. To improve the survival rate, novel therapeutic targets for PDAC are still urgently needed. KIF18B was initially identified...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Microtubule and mitosis dynamics
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31875977
DOI: 10.1002/jcp.29201

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KIF18B promotes the proliferation of pancreatic ductal adenocarcinoma via activating the expression of CDCA8PMID 31875977Read ↗

Comprehensive Analysis of Expression, Prognosis and Immune Infiltrates for Kinesin Superfamily Members in Human Pancreatic AdenocarcinomaSemantic proximity Read ↗

Upregulation of KIF18B facilitates malignant phenotype of esophageal squamous cell carcinoma by activating CDCA8/mTORC1 pathway.Semantic proximity Read ↗

KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic targetSemantic proximity Read ↗

A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cellsSemantic proximity Read ↗

KIFC1 overexpression promotes pancreatic carcinoma progression via stabilizing BUB1Semantic proximity Read ↗

Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell CycleSemantic proximity Read ↗

A pan-cancer exploration of kinesin family member 20A (KIF20A)'s oncogenic activity in human tumorsSemantic proximity Read ↗

Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-CancerSemantic proximity Read ↗

A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer.Semantic proximity Read ↗

KIFC1 overexpression promotes pancreatic carcinoma progression via the BUB1/WNT/β- catenin pathwaySemantic proximity Read ↗

CKS2 Predicts A Poor Prognosis and Contributes to Malignant Progression of Pancreatic CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.